Skip Nav Destination

Issue Archive

Select Year

Issue

Volume 10, Issue 3

May-June 2013

In this Issue

Ask the Hematologist
Clinical Trials Corner
Diffusion
Mini Review
President’s Column

Ask the Hematologist

Ask the Hematologist: May-June 2013

Charles S. Abrams, MD

View Articletitled, Ask the Hematologist: May-June 2013

Clinical Trials Corner

Factor VIII and IX: Making a Long-Lasting Impression

Margaret V. Ragni, MD, MPH

View Articletitled, Factor VIII and IX: Making a Long-Lasting Impression

Diffusion

Stitching Trainers Together to Subtype Diffuse Large B-Cell Lymphoma

Peter Johnson, MD

View Articletitled, Stitching Trainers Together to Subtype Diffuse Large B-Cell Lymphoma

Balancing the Stem Cell Budget

Peter Kurre, MD

View Articletitled, Balancing the Stem Cell Budget

The Benefits of a SeXist RNA

Jason Gotlib, MD, MS

View Articletitled, The Benefits of a SeXist RNA

Selective Therapeutic Targeting of iNKT Cell-Mediated Inflammation in Sickle Cell Anemia

Charles T. Quinn, MD, MS

View Articletitled, Selective Therapeutic Targeting of iNKT Cell-Mediated Inflammation in Sickle Cell Anemia

Nucleic Acid Scavengers: Upsetting the Yin and Yang of Hemostasis?

Pete Lollar, MD

View Articletitled, Nucleic Acid Scavengers: Upsetting the Yin and Yang of Hemostasis?

The Effects of Leukemogenic Isocitrate Dehydrogenase 1 Mutations on Proliferation and Differentiation are Reversible

David P. Steensma, MD

View Articletitled, The Effects of Leukemogenic Isocitrate Dehydrogenase 1 Mutations on Proliferation and Differentiation are Reversible

Knowing When to Stop: Cell Cycle, MCV, and RB C Count

Mark J. Koury, MD

View Articletitled, Knowing When to Stop: Cell Cycle, MCV, and RB C Count

Medicine for the Heart: ADAMTS 13 in Mice, and Maybe Men

Margaret V. Ragni, MD, MPH

View Articletitled, Medicine for the Heart: ADAMTS 13 in Mice, and Maybe Men

Not PAR for a GPCR

Robert Flaumenhaft, MD, PhD

View Articletitled, Not PAR for a GPCR

All in the Family: Fine Tuning Targeted Attack on BCL-2

Pamela S. Becker, MD, PhD

View Articletitled, All in the Family: Fine Tuning Targeted Attack on BCL-2

Mini Review

Inhibition of B-Cell Receptor Signaling as a Therapeutic Strategy for Treatment of CLL

J. Brice Weinberg, MD,Daphne R. Friedman, MD

View Articletitled, Inhibition of B-Cell Receptor Signaling as a Therapeutic Strategy for Treatment of CLL

President’s Column

President's Column - Sickle Cell Trait and Sports: Is the NCAA a Hematologist?

Janis L. Abkowitz, MD

View Articletitled, President's Column - Sickle Cell Trait and Sports: Is the NCAA a Hematologist?

Cover Image

Cover Image

All Issues

Advertisement intended for health care professionals

Email alerts

Latest Issue Alert

Continuous Publishing Alert

New Journal Content Alert

Latest
Most Read

Vitamin A to Keep GVHD Away: Single Oral High-Dose Vitamin A Before Bone Marrow Transplant Reduces Graft-Versus-Host Disease in Pediatric and Young Adult Patients

Trainee Corner
A Career in Academia: Should I Stay or Should I Go?

Then and Now
Treatment for Acute Leukemia in Older Adults: Two Decades of Remarkable Progress

Does Sustained Monocytosis Always Mean CMML? A Case of Ras-Associated Autoimmune Leukoproliferative Disorder

ASH and Federal Officials Hold Town Hall on Sickle Cell Disease

Advertisement intended for health care professionals

Table of Contents

Ask the Hematologist

Ask the Hematologist: May-June 2013

Clinical Trials Corner

Factor VIII and IX: Making a Long-Lasting Impression

Diffusion

Stitching Trainers Together to Subtype Diffuse Large B-Cell Lymphoma

Balancing the Stem Cell Budget

The Benefits of a SeXist RNA

Selective Therapeutic Targeting of iNKT Cell-Mediated Inflammation in Sickle Cell Anemia

Nucleic Acid Scavengers: Upsetting the Yin and Yang of Hemostasis?

The Effects of Leukemogenic Isocitrate Dehydrogenase 1 Mutations on Proliferation and Differentiation are Reversible

Knowing When to Stop: Cell Cycle, MCV, and RB C Count

Medicine for the Heart: ADAMTS 13 in Mice, and Maybe Men

Not PAR for a GPCR

All in the Family: Fine Tuning Targeted Attack on BCL-2

Mini Review

Inhibition of B-Cell Receptor Signaling as a Therapeutic Strategy for Treatment of CLL

President’s Column

President's Column - Sickle Cell Trait and Sports: Is the NCAA a Hematologist?

Email alerts

ASH Publications

American Society of Hematology

Issue Archive

Table of Contents

Ask the Hematologist

Clinical Trials Corner

Diffusion

Mini Review

President’s Column

Cover Image

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only